| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |